The DNA damage response (DDR) is a complex regulatory network that is critical for maintaining genome integrity. Posttranslational modifications are widely used to ensure strict spatiotemporal control of signal flow, but how the DDR responds to environmental cues, such as changes in ambient oxygen tension, remains poorly understood. We found that an essential component of the ATR/CHK1 signaling pathway, the human homolog of the Caenorhabditis elegans biological clock protein CLK-2 (HCLK2), associated with and was hydroxylated by prolyl hydroxylase domain protein 3 (PHD3). HCLK2 hydroxylation was necessary for its interaction with ATR and the subsequent activation of ATR/CHK1/p53. Inhibiting PHD3, either with the pan-hydroxylase inhibitor dimethyloxaloylglycine (DMOG) or through hypoxia, prevented activation of the ATR/CHK1/p53 pathway and decreased apoptosis induced by DNA damage. Consistent with these observations, we found that mice lacking PHD3 were resistant to the effects of ionizing radiation and had decreased thymic apoptosis, a biomarker of genomic integrity. Our identification of HCLK2 as a substrate of PHD3 reveals the mechanism through which hypoxia inhibits the DDR, suggesting hydroxylation of HCLK2 is a potential therapeutic target for regulating the ATR/CHK1/p53 pathway.
Liang Xie, Xinchun Pi, Ashutosh Mishra, Guohua Fong, Junmin Peng, Cam Patterson
Title and authors | Publication | Year |
---|---|---|
PHD1-3 oxygen sensors in vivo-lessons learned from gene deletions.
Jucht AE, Scholz CC |
2024 | |
Endothelial EGLN3-PKM2 signaling induces the formation of acute astrocytic barrier to alleviate immune cell infiltration after subarachnoid hemorrhage
Duan M, Ru X, Zhou J, Li Y, Guo P, Kang W, Li W, Chen Z, Feng H, Chen Y |
Fluids and barriers of the CNS | 2024 |
Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance
Carney SV, Banerjee K, Mujeeb A, Zhu B, Haase S, Varela ML, Kadiyala P, Tronrud CE, Zhu Z, Mukherji D, Gorla P, Sun Y, Tagett R, Núñez FJ, Luo M, Luo W, Ljungman M, Liu Y, Xia Z, Schwendeman A, Qin T, Sartor MA, Costello JF, Cahill DP, Lowenstein PR, Castro MG |
Clinical cancer research | 2023 |
PHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway: PHD3 inhibits metastasis via occludin-p38 MAPK
Li Y, Yuan T, Zhang H, Liu S, Lun J, Guo J, Wang Y, Zhang Y, Fang J |
Acta Biochimica et Biophysica Sinica | 2023 |
Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke.
Xie J, Zhang Z |
Molecular Neurobiology | 2023 |
Oxygen‐regulated post‐translation modifications as master signalling pathway in cells
Batie M, Fasanya T, Kenneth NS, Rocha S |
EMBO reports | 2023 |
Integrated systems biology approach identifies gene targets for endothelial dysfunction
Pinheiro\u2010de\u2010Sousa I, Fonseca\u2010Alaniz MH, Giudice G, Valadão IC, Modestia SM, Mattioli SV, Junior RR, Zalmas L, Fang Y, Petsalaki E, Krieger JE |
Molecular Systems Biology | 2023 |
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth
Y Jin, Y Pan, S Zheng, Y Liu, J Xu, Y Peng, Z Zhang, Y Wang, Y Xiong, L Xu, K Mu, S Chen, F Zheng, Y Yuan, J Fu |
Oncogene | 2022 |
Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity
J Li, C Chen, C Li, Z Hu, J Tan, L Zeng |
Frontiers in Cell and Developmental Biology | 2022 |
Endothelial Transient Receptor Potential Canonical Channel Regulates Angiogenesis and Promotes Recovery After Myocardial Infarction
X Wen, Y Peng, M Gao, Y Zhu, Y Zhu, F Yu, T Zhou, J Shao, L Feng, X Ma |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2022 |
PHD3 inhibits cell proliferation through hydroxylation of PAX2 at proline 9: PHD3 hydroxylates PAX2
Lun J, Wang Y, Gao Q, Wang Y, Zhang H, Fang J |
Acta Biochimica et Biophysica Sinica | 2022 |
Role of Hypoxia in the Control of the Cell Cycle
J Druker, JW Wilson, F Child, D Shakir, T Fasanya, S Rocha |
International journal of molecular sciences | 2021 |
Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins
SJ Wong, AE Ringel, W Yuan, JA Paulo, H Yoon, MA Currie, MC Haigis |
The Journal of biological chemistry | 2021 |
Prolyl hydroxylase 3 controls the intestine goblet cell generation through stabilizing ATOH1
Y Xu, Q Gao, J Zhang, Y Lu, D Xing, Y Qin, J Fang |
Cell Death and Differentiation | 2020 |
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
A Reustle, MD Marco, C Meyerhoff, A Nelde, JS Walz, S Winter, S Kandabarau, F Büttner, M Haag, L Backert, DJ Kowalewski, S Rausch, J Hennenlotter, V Stühler, M Scharpf, F Fend, A Stenzl, HG Rammensee, J Bedke, S Stevanović, M Schwab, E Schaeffeler |
Genome Medicine | 2020 |
NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial–Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production
WN Xu, RZ Yang, HL Zheng, LS Jiang, SD Jiang |
Frontiers in Cell and Developmental Biology | 2020 |
Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress: NDUFA4L2 promotes LC cell vitality
L Meng, X Yang, X Xie, M Wang |
Thoracic Cancer | 2019 |
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53–MDM2 interaction in a hydroxylase-independent manner
Y Xu, Q Gao, Y Xue, X Li, L Xu, C Li, Y Qin, J Fang |
The Journal of biological chemistry | 2019 |
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
S Li, J Rodriguez, W Li, P Bullova, SM Fell, O Surova, I Westerlund, D Topcic, M Bergsland, A Stenman, J Muhr, M Nistér, J Holmberg, CC Juhlin, C Larsson, A von Kriegsheim, WG Kaelin, S Schlisio |
Proceedings of the National Academy of Sciences | 2019 |
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
ME Cockman, K Lippl, YM Tian, HB Pegg, WD Jnr, MI Abboud, R Heilig, R Fischer, J Myllyharju, CJ Schofield, PJ Ratcliffe |
eLife | 2019 |
Prolyl hydroxylase domain-2 protein regulates lipopolysaccharide-induced vascular inflammation
Q Fan, H Mao, L Xie, X Pi |
The American Journal of Pathology | 2018 |
Hypoxic Signalling in Tumour Stroma
A Laitala, JT Erler |
Frontiers in Oncology | 2018 |
PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
J Rodriguez, A Herrero, S Li, N Rauch, A Quintanilla, K Wynne, A Krstic, JC Acosta, C Taylor, S Schlisio, A von Kriegsheim |
Cell Reports | 2018 |
Simvastatin ameliorates ionizing radiation-induced apoptosis in the thymus by activating the AKT/sirtuin 1 pathway in mice
H Yang, F Huang, Y Tao, X Zhao, L Liao, X Tao |
International journal of molecular medicine | 2017 |
Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair
SK Ghadge, M Messner, TV Pham, M Doppelhammer, A Petry, A Görlach, B Husse, WM Franz, MM Zaruba |
Journal of Molecular Medicine | 2017 |
PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis
ZR Schoepflin, ES Silagi, IM Shapiro, MV Risbud |
The FASEB Journal | 2017 |
PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
RF Koncar, Z Chu, LE Romick-Rosendale, SI Wells, TA Chan, X Qi, EM Bahassi |
Oncotarget | 2017 |
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes
A Stoehr, Y Yang, S Patel, AM Evangelista, A Aponte, G Wang, P Liu, J Boylston, PH Kloner, Y Lin, M Gucek, J Zhu, E Murphy |
Cardiovascular Research | 2016 |
Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways
J Rodriguez, R Pilkington, A Garcia Munoz, LK Nguyen, N Rauch, S Kennedy, N Monsefi, A Herrero, CT Taylor, A von Kriegsheim |
Cell Reports | 2016 |
PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban
Liang Xie, Xinchun Pi, W.H. Davin Townley-Tilson, Li Na, Xander H.T. Wehrens, Mark L. Entman, George E. Taffet, Ashutosh Mishra, Junmin Peng, Jonathan Schisler, Gerhard Meissner, Cam Patterson |
Journal of Clinical Investigation | 2015 |
PHD1 regulates p53-mediated colorectal cancer chemoresistance
S Deschoemaeker, GD Conza, S Lilla, R Martin-Perez, D Mennerich, L Boon, S Hendrikx, OD Maddocks, C Marx, P Radhakrishnan, H Prenen, M Schneider, J Myllyharju, T Kietzmann, KH Vousden, S Zanivan, M Mazzone |
EMBO Molecular Medicine | 2015 |
The role of hypoxia in inflammatory disease (Review)
J Biddlestone, D Bandarra, S Rocha |
International journal of molecular medicine | 2015 |
PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function
Y Chen, HS Zhang, GH Fong, QL Xi, GH Wu, CG Bai, ZQ Ling, L Fan, YM Xu, YQ Qin, TL Yuan, H Sun, J Fang |
The Journal of biological chemistry | 2015 |
Depletion of PHD3 Protects Heart from Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis
L Xie, X Pi, Z Wang, J He, MS Willis, C Patterson |
Journal of Molecular and Cellular Cardiology | 2015 |
Identification of prolyl hydroxylation modifications in mammalian cell proteins
PR Arsenault, KJ Heaton-Johnson, L Li, D Song, VS Ferreira, N Patel, SR Master, FS Lee |
PROTEOMICS | 2015 |
Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
S Kim, E Yang |
Molecules (Basel, Switzerland) | 2015 |
CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells
B Ortmann, D Bensaddek, S Carvalhal, SC Moser, S Mudie, ER Griffis, JR Swedlow, AI Lamond, S Rocha |
Journal of cell science | 2015 |
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
P Pollard, M Yang, H Su, T Soga, K Kranc |
Hypoxia | 2014 |
Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions
L Swain, M Wottawa, A Hillemann, A Beneke, H Odagiri, K Terada, M Endo, Y Oike, K Farhat, DM Katschinski |
Journal of leukocyte biology | 2014 |
Cell cycle progression in response to oxygen levels
B Ortmann, J Druker, S Rocha |
Cellular and Molecular Life Sciences | 2014 |
PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility
W Luo, B Lin, Y Wang, J Zhong, R O'Meally, RN Cole, A Pandey, A Levchenko, GL Semenza |
Molecular biology of the cell | 2014 |
Prolyl-hydroxylase 3: Evolving Roles for an Ancient Signaling Protein
TL Place, FE Domann |
2013 | |
PHD1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192
SC Moser, D Bensaddek, B Ortmann, JF Maure, S Mudie, JJ Blow, AI Lamond, JR Swedlow, S Rocha |
Developmental Cell | 2013 |
Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition
TL Place, JT Nauseef, MK Peterson, MD Henry, JJ Mezhir, FE Domann |
PloS one | 2013 |
Centrosomes tune in to metabolic state and turn on to oxygen
SK and, BD Dynlacht |
Developmental Cell | 2013 |